Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating dopamine in Raynaud's phenomenon.

B Marasini1, M L Biondi, A Agostoni

  • 1Clinica Medica V, Ospedale S. Paolo, University of Milan, Italy.

Angiology
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outbreak Investigation of Influenza in Pajaru VDC of Jajarkot District of Nepal.

Journal of Nepal Health Research Council·2017
Same author

Statins and cardiovascular risk in rheumatic diseases.

International journal of immunopathology and pharmacology·2012
Same author

Shock wave therapy for systemic sclerosis.

Rheumatology international·2011
Same author

Systemic sclerosis and cancer.

International journal of immunopathology and pharmacology·2009
Same author

Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2009
Same author

The safety of anti-TNF agents in the elderly.

International journal of immunopathology and pharmacology·2009
Same journal

Refining Phenotype-Based Interpretation of SGLT2 Inhibitors After AMI Without Heart Failure.

Angiology·2026
Same journal

Response to: "Integrating Noninvasive Liver Indices into Risk Stratification of Myocardial Infarction With Non-Obstructive Coronary Arteries".

Angiology·2026
Same journal

Response to: "Beyond Traditional Risk Markers: Is FIB-4 Sufficient in MINOCA?"

Angiology·2026
Same journal

Letter: Further Considerations on the Clinical Use of the Scottish Inflammatory Prognostic Score in STEMI No-Reflow Prediction.

Angiology·2026
Same journal

Contextualizing Remodeling Endpoints in Endovascular Treatment for Symptomatic SISMAD.

Angiology·2026
Same journal

<i>Response to the Letter to the Editor</i>: "Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial Infarction".

Angiology·2026
See all related articles

Raynaud

Area of Science:

  • Biochemistry
  • Pharmacology
  • Clinical Medicine

Background:

  • Raynaud's phenomenon involves episodic vasospasm.
  • Neurotransmitter levels in Raynaud's patients are not fully understood.

Purpose of the Study:

  • To investigate plasma and intraplatelet catecholamine levels in Raynaud's phenomenon.
  • To compare neurotransmitter levels between patients and controls.

Main Methods:

  • High-performance liquid chromatography with electrochemical detection.
  • Analysis of plasma and intraplatelet dopamine, norepinephrine, and epinephrine.
  • Study included 20 subjects with Raynaud's phenomenon and controls.

Main Results:

  • Significantly lower plasma free dopamine and epinephrine in Raynaud's patients compared to controls.

Related Experiment Videos

  • Normal plasma conjugated and intraplatelet catecholamine levels.
  • No abnormalities in norepinephrine levels were observed.

    • Conclusions:

    • Reduced circulating free dopamine and epinephrine may contribute to Raynaud's pathophysiology.
    • Potential mechanisms include impaired adrenal release or increased peripheral metabolism.
    • A postischemic dopaminergic vasodilation system is proposed.